|
Volume 271, Number 36,
Issue of September 6, 1996
pp. 22117-22124
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Interaction of Kinesin Motor Domains with - and -Tubulin
Subunits at a Tau-independent Binding Site
REGULATION BY POLYGLUTAMYLATION*
(Received for publication, March 5, 1996, and in revised form, May 17, 1996)
Jean-Christophe
Larcher
,
Dominique
Boucher
,
Sylvie
Lazereg
,
François
Gros
and
Philippe
Denoulet
From the Biochimie Cellulaire, CNRS UPR 9065 and the
Université P. & M. Curie, Collège de France, 11 place
Marcelin Berthelot, 75005 Paris, France
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
Interaction of rat kinesin and
Drosophila nonclaret disjunctional motor domains with
tubulin was studied by a blot overlay assay. Either plus-end or
minus-end-directed motor domain binds at the same extent to both -
and -tubulin subunits, suggesting that kinesin binding is an
intrinsic property of each tubulin subunit and that motor
directionality cannot be related to a preferential interaction with a
given tubulin subunit. Binding features of dimeric versus
monomeric rat kinesin heads suggest that dimerization could drive
conformational changes to enhance binding to tubulin. Competition
experiments have indicated that kinesin interacts with tubulin at a
Tau-independent binding site. Complementary experiments have shown that
kinesin does not interact with the same efficiency with the different
tubulin isoforms. Masking the polyglutamyl chains with a specific
monoclonal antibody leads to a complete inhibition of kinesin binding.
These results are consistent with a model in which polyglutamylation of
tubulin regulates kinesin binding through progressive conformational
changes of the whole carboxyl-terminal domain of tubulin as a function
of the polyglutamyl chain length, thus modulating the affinity of
tubulin for kinesin and Tau as well. These results indicate that
microtubules, through tubulin polymorphism, do have the ability to
control microtubule-associated protein binding.
INTRODUCTION
The various structures and functions of microtubule
(MT)1 networks are mediated by many
different structural and motor microtubule-associated proteins (MAPs)
(for review see Refs. 1, 2, 3, 4). To coordinate these functions, the major
problem in cells is to regulate not only the expression of the
different MAPs but, more precisely, their differential interactions
with MTs. Regulation of MAP binding through phosphorylation has been
extensively documented (5, 6, 7), although little information is as yet
available concerning motor proteins (8, 9, 10, 11). However, several reports
have clearly shown that part of this regulation had also to be
supported by the MTs themselves. For instance, it has been shown that
in lobster axons, only a subset of MTs was competent for vesicle
transport (12), suggesting that the MT surface available for
interaction with motors was not homogeneous along all of the axonal
MTs. The same relationship between distinct MT subsets and specific
binding of kinesin-like proteins has also been observed in the mitotic
spindle apparatus (13, 14, 15) and in the Chlamydomonas
flagellum where Klp1 was shown to interact selectively with the central
pair C2 MT (16). The chemical diversity of the MT surface could provide
such specific positional and binding information in cells for many
MT-interacting proteins. The large genetic and post-translational
heterogeneity of the - and -tubulin subunits (for review see
Refs. 17, 18, 19) can represent the molecular bases for such information.
Indeed, we recently showed that polyglutamylation, the oligomeric
post-translational modification of tubulin (20, 21, 22, 23), was involved in
the regulation of Tau and MAP2 interaction with tubulin through a
modulation of affinity as a function of the polyglutamyl chain length
(24). Because, on one hand, the extension of the polyglutamyl chain
from one to six units is thought to induce conformational changes in
the carboxyl-terminal domain of both tubulin subunits, leading to the
observed modulation of affinity for structural MAPs, and, on the other
hand, all of the known MT-based motors (kinesin, kinesin-related
proteins, and cytoplasmic and flagellar dyneins) have been reported to
bind also in this carboxyl-terminal domain (25, 26), it follows that
their binding could also be under the same control as the structural
MAPs.
We have analyzed the binding of different kinesin head motor domains
(conventional rat kinesin (RK) and the Drosophila
minus-end-directed kinesin-related protein (ncd, for nonclaret
disjunctional)) to tubulin and investigated the influence of the degree
of polyglutamylation of the various - and -tubulin isoforms on
motor binding. In this paper, we report that the two types of motors
bind in vitro to both - and -tubulin subunits and that
this interaction appears to be controlled by polyglutamylation in the
same manner as for Tau or MAP2. In addition, competition experiments
carried out with several monoclonal antibodies and with kinesin heads
and heat-stable MAPs indicate that the respective binding sites of
structural and motor MAPs are independent from each other, although
located in a sufficiently close vicinity on the tubulin molecule to
undergo the same conformational control by polyglutamylation.
EXPERIMENTAL PROCEDURES
Antibodies
The monoclonal antibodies DM1A and DM1B were
purchased from Amersham Corp., Tau-1 was from Boehringer Mannheim, and
anti-MAP2 was from Sigma. The monoclonals YL1/2 and
YOL1/34 were generous gifts of Dr. J. Kilmartin (M.R.C. Laboratory of
Molecular Biology, Cambridge, UK). The polyclonal anti-HIPYR (14) was
kindly provided by Dr. T. Mitchison (Department of Pharmacology,
University of California, San Francisco, CA). The GT335 monoclonal
antibody was produced in our laboratory (27).
Recombinant Proteins
The recombinant motor domain
constructs of rat kinesin (RK375 and RK329) and Drosophila
ncd (HA-N333) were kindly provided by E.-M. Mandelkow and F. Kozielski
(Max-Planck Unit for Structural Molecular Biology, Hamburg, Germany).
RK375 and RK329 correspond to amino acids 1-379 and 1-329 of the rat
kinesin sequence, respectively. HA-N333 corresponds to amino acids
333-700 of the Drosophila claret segregational protein
sequence.
Protein Purification
Tubulin was prepared from a 100,000 × g supernatant of adult mouse brain by two cycles of assembly
disassembly and further purified by phosphocellulose column
chromatography (P11, Whatman) in MEM buffer (50 mM MES, pH
6.8, 2 mM EGTA, 2 mM MgCl2)
containing 1 mM Mg-GTP and a mixture of protease inhibitors
(10 µg·ml 1 aprotinin, 10 µg·ml 1
leupeptin, 1 mM phenylmethylsulfonyl fluoride). Heat-stable
MAPs (essentially Tau and MAP2) were routinely prepared from once
cycled MTs, which were depolymerized at 4 °C, cleared by
centrifugation, brought to 0.5 M NaCl, and boiled for 5 min.
Subtilisin Digestion
Purified brain tubulin (1 mg·ml 1) was digested in MEM buffer with 1.25 or 5 µg·ml 1 subtilisin (Carlsberg, Sigma;
7-15 units·mg 1) for 45 min at 37 °C, leading to a
limited or a total digestion of tubulin, respectively. Reaction was
stopped by the addition of 1 mM phenylmethylsulfonyl
fluoride, and aliquots were processed by one-dimensional PAGE.
One-dimensional and Two-dimensional PAGE
Protein separation
by one-dimensional or two-dimensional PAGE and immunodetection was
carried out as described previously (24, 27) except that ampholytes
5-6 (Serva) were used in the isoelectric focusing dimension. Antibody
binding was revealed by the ECL system (Amersham Corp.), and
autoradiographs were quantified by scanning using a Vernon integrating
densitometer.
Blot Overlay Assay
Binding of kinesin heads to tubulin
separated by one-dimensional or two-dimensional PAGE and transferred
onto nitrocellulose membranes (Hybond C, Amersham Corp.) was performed
essentially as described previously (24). Briefly, after monitoring of
blotted tubulin by Ponceau red staining, strips corresponding to lanes
of one-dimensional gels (or rectangles corresponding to tubulin regions
of two-dimensional gels) were cut from the blots and placed into the
grooves of a hand-made, Plexiglas incubation device adjusted to the
size of the strips. Nitrocellulose pieces were blocked overnight in
overlay buffer (OV = MEM buffer containing 1 mM
dithiothreitol, 0.1% (v/v) Tween 20, and 0.1% (w/v) gelatin),
incubated for 1 h at 20 °C with the overlaying protein
fraction, and then washed 5 × 10 min. Protein interactions were
then stabilized with formaldehyde (24) before the blots were
equilibrated in TBS-T (20 mM Tris, pH 7.5, 136.8 mM NaCl, 0.1% Tween 20) and processed for immunodetection.
Kinesin Binding to Coated Tubulin
Heterodimers
Phosphocellulose-purified tubulin (1 µg in 100 µl/well) was coated onto enzyme-linked immunosorbent assay multiwell
microtiter plates (Nunc) in MEM buffer at 37 °C. We checked by
immunoassay that a constant amount of 500 ng was actually coated in
each well according to the manufacturer. Wells were equilibrated and
blocked overnight in OV then incubated with various concentrations of
kinesin heads in 100 µl for 60 min at 25 °C. Wells were rinsed
with OV (5 × 5 min), and kinesin-tubulin interactions were
stabilized with formaldehyde (24). After equilibration in TBS-T,
tubulin-bound kinesin was detected with anti-HIPYR 2 h at 37 °C
and a -galactosidase-conjugated secondary anti-rabbit IgG (Biosys,
France) 1 h at 37 °C, using
o-nitrophenyl- -D-galactoside
(Sigma) as chromogen. Reactions were quantified
automatically at 490 nm.
Microtubule Sedimentation Assay
MTs were polymerized from a
whole brain supernatant in the presence of 20 µM Taxol
and washed with 0.5 M NaCl to remove bound MAPs. MTs were
pelleted, resuspended in MEM buffer, and used in micro-assays of
kinesin head binding. MTs (60 pmol) were mixed with kinesin heads (50 pmol) in the absence or the presence of different nucleotides and salt
in a final volume of 25 µl. After centrifugation (10 min at 25 p.s.i. in the A100 Airfuge rotor, Beckman), the whole pellet and
supernatant proteins were analyzed by one-dimensional PAGE.
Size Exclusion HPLC
RK329 and RK375 were suspended in MEM
buffer (with or without 500 mM NaCl), cleared 10 min at
12,000 × g, and analyzed (separately or mixed) by gel
filtration HPLC (Waters) on a TSK G3000 column (7.8 × 300 mm)
equilibrated in MEM buffer and calibrated with standard proteins.
Protein elution (1 ml·min 1) was monitored at 280 nm.
Proteins from each collected fraction were analyzed by one-dimensional
PAGE, detected by Coomassie blue staining and immunoprobed with
anti-HIPYR antibodies.
RESULTS
Interaction of Rat Kinesin Heads (RK375) with - and -Tubulin
Subunits
Increasing concentrations of RK head were overlaid onto
a constant amount of tubulin separated by one-dimensional PAGE and
immobilized onto nitrocellulose. Fig. 1A
shows that RK head binding, detected on both - and -tubulin
subunits with the specific anti-kinesin peptide (HIPYR) antibody,
increased proportionally with RK concentration up to a saturation
value. RK375 binding to both - and -tubulin was progressively
inhibited when increasing concentrations of free tubulin were added to
the overlay solution (Fig. 1B, left panel). A
selective binding to both tubulin subunits was also observed when RK375
was overlaid onto whole supernatant proteins from brain (Fig.
1B, right panel). These results indicate that the
tubulin-kinesin interactions occurring during the blot overlay
procedure were specific. Likewise, the reverse, minus-end-directed
motor head of ncd also bound to both - and -tubulin subunits
(Fig. 1C), suggesting that the directionality of a kinesin
motor protein along a MT is not determined by its selective interaction
with a given - or -tubulin subunit.
Fig. 1.
RK375 and ncd head domain binding to - and
-tubulin subunits. A, phosphocellulose-purified tubulin
(2 µg) was separated by one-dimensional PAGE, blotted onto
nitrocellulose, and overlaid with increasing concentrations of RK375
(from 0 to 10 µg·ml 1) in 1 ml of OV buffer. Kinesin
bound to separated - and -tubulin subunits was detected with
anti-HIPYR antibody, and the resulting signals (upper panel)
were quantified by densitometric scanning (expressed in arbitrary
units, lower panel). B, to check the specificity
of RK375 binding to tubulin, 2 µg·ml 1 of RK375 (the
concentration used in the following experiments) were overlaid onto
whole supernatant proteins from brain (So)
separated by one-dimensional PAGE. In these conditions, kinesin
binding, revealed by anti-HIPYR, was limited to tubulin
(dashes, right panel). In addition, when
increasing concentrations of competitive free tubulin were added to the
overlay solution (containing 2 µg·ml 1 RK375), a
concomitant inhibition of RK binding to both tubulin subunits was
observed (left panel). C, same experiment as in
A except that the motor head of the minus-end-directed
kinesin-related protein ncd was substituted to RK375.
[View Larger Version of this Image (19K GIF file)]
To assess the in vitro binding assay used in the preceding
experiments, RK head binding was tested in the presence of nucleotides.
Kinesin binding was progressively inhibited by increasing
concentrations of GTP or of its hydrolyzable form, Mg-GTP (Fig.
2A). The effect of nucleotides on RK head
binding was also tested using heterodimeric tubulin coated onto
multiwell enzyme-linked immunosorbent assay plates and taxol-stabilized
MTs by a sedimentation assay. Fig. 2 (B and C)
shows that in both cases the binding of RK heads was weakened by GTP,
indicating that monomeric tubulin in the blot overlay assay behaves as
heterodimeric or MT-assembled tubulin with respect to kinesin head
binding.
Fig. 2.
RK375 binding to monomeric, heterodimeric,
and polymerized tubulin. A, for each experiment, 2 µg of
tubulin separated by one-dimensional PAGE and blotted onto
nitrocellulose were overlaid with 2 µg·ml 1 of RK375
in OV containing 0-5 mM of either GTP or Mg-GTP. Kinesin
bound to separated - and -tubulin subunits ( T and T) was
detected with anti-HIPYR antibody, and the resulting signals were
quantified by densitometric scanning (expressed in arbitrary units).
B, RK375 binding, under different motor concentrations (0-5
µg in 100 µl) was assayed in an enzyme-linked immunosorbent
assay-type experiment with heterodimeric tubulin coated onto microtiter
plates in the absence or the presence (1 and 5 mM) of GTP.
C, MTs were incubated with RK375 in the absence
(Control) or the presence of 5 mM GTP or 200 mM NaCl. After centrifugation, proteins recovered in the
pellet (P) or the supernatant (S) were separated
by one-dimensional PAGE and stained with Coomassie Blue. D,
same type of experiment as in A where tubulin-RK375
interactions were carried out in the presence of increasing
concentrations of NaCl (0-100 mM).
[View Larger Version of this Image (33K GIF file)]
Formation of RK head-tubulin complexes was also readily prevented by
raising the salt concentration in the incubation medium (Fig. 2,
C and D). No interaction could be detected beyond
75 mM NaCl. Formation of kinesin-tubulin complexes was
still effective, however, in the presence of 1 or 2 M urea
(data not shown). These results indicate that kinesin-tubulin
interactions occur mainly through electrostatic bonds.
It is interesting to note that when MES was substituted by PIPES, the
binding efficiency of kinesin to tubulin dropped severalfold. At 100 mM PIPES, a widely used buffer molarity, however, binding
was faintly detectable, at levels 5-10 times lower than with 50 mM MES (data not shown).
In all of these experiments where nucleotides, salt, chaotropic agent,
or buffers were tested, the variation in the binding of RK heads was
always similar for - and -tubulin subunits, indicating that the
same basic binding features for kinesin were shared by both subunits,
which in turn suggests the involvement of related sequences in
orthologous domains in both subunits.
Binding of a Truncated Rat Kinesin Motor Domain
When a
truncated derivative of RK head, RK329, was overlaid onto immobilized
tubulin (Fig. 3A), the resulting binding was
estimated to be 5-10-fold lower than that obtained with the whole
RK375 head. Although less efficiently, RK329 bound to both tubulin
subunits at similar levels. The same difference in tubulin binding was
observed when increasing concentrations of RK375 and RK329 were added
to microwells coated with heterodimeric tubulin (Fig. 3B).
These results suggest that amino acids 330-375 of RK are important for
enhancing the interaction with tubulin.
Fig. 3.
Binding of RK329 versus RK375.
A, 2 µg of tubulin separated by one-dimensional PAGE and
blotted onto nitrocellulose were overlaid with 2 and 10 µg·ml 1 of RK329 or RK375, and the resulting signals
(insert) were quantified. B, increasing
concentrations (0-5 µg in 100 µl) of RK329 or RK375 were added to
wells of microtiter plates coated with 500 ng of tubulin. In both types
of experiment, kinesin head binding to tubulin was revealed with
anti-HIPYR antibody and quantified (expressed in arbitrary units).
C, 50 µg of each RK329 and RK375 were mixed in MEM buffer
and separated by size exclusion chromatography. Protein elution (1 ml·min 1) was monitored at 280 nm (solid
line). After equilibration of the column with MEM containing 500 mM NaCl, 75 µg of RK375 in MEM-NaCl were
rechromatographed (dotted line). D, aliquots of
fractions collected from the first run were analyzed by one-dimensional
PAGE. Lane 1, RK329, control; lane 2, RK375,
control; lane 3, RK329 + RK375, control; lane 4,
peak 1 (7.8 min); lane 5, peak 2 (9.3 min); lane
6, peak 3 (11.3 min). Left panel, Coomassie Blue
staining; right panel, anti-HIPYR immunodetection. Peak 3 contained no protein; absorbance at 280 nm was due to the presence of
traces of sodium azide, dithiothreitol, and ATP in the loaded
samples.
[View Larger Version of this Image (25K GIF file)]
RK329 and RK375 were then analyzed by gel filtration chromatography to
check the assembly state of each motor. Fig. 3, (C and
D) shows that RK329 (calculated mass, 36.8 kDa) and RK375
(calculated mass, 42.7 kDa) each eluted as a single peak (retention
times, 9.3 and 7.8 min, respectively) corresponding to globular
polypeptides of Mr 37,200 and 120,000, respectively. Given the steric occupancy of a nonspherical, two-headed
protein, these values are compatible with a dimerized state of RK375.
When the column was run in 500 mM NaCl, RK375 eluted at the
same position (Fig. 3C, dotted line). The salt
resistance of RK375 dimers suggests that -helical coiled-coil
interactions could be involved between amino acids 330-375 of kinesin
sequences (see Ref. 28 and ``Discussion'').
Regulation of Kinesin-Tubulin Interaction by
Polyglutamylation
Because polyglutamylation was previously shown
to modulate the affinity of tubulin for the structural MAPs Tau and
MAP2 (24), we researched whether it could also be involved in the
control of the binding of kinesin. Brain tubulin was separated by
resolutive two-dimensional PAGE to physically space the different
isoforms carrying an increasing number of glutamyl units (22, 24) and
transferred onto nitrocellulose. The different isotubulins were then
probed for their ability to interact with kinesin. By comparison with
the whole set of tubulin isoforms available on the nitrocellulose
membrane (Fig. 4A), as detected with general
anti-tubulin antibodies, Fig. 4B shows that RK375,
immunodetected with anti-HIPYR, does not interact with the same
efficiency with all of the different forms of tubulin. As previously
observed for Tau (24), kinesin interacted principally with moderately
modified - and -isotubulins. The unmodified, more basic, primary
translation products as well as the fully modified, more acidic
isoforms only bound weakly, if at all, to kinesin. Because the type of
response was similar for - and -tubulin and involved
post-translationally derived tubulin isoforms, polyglutamylation
appeared as the only obvious candidate responsible for this
differential kinesin binding; it is the only modification that occurs
on both tubulin subunits (Fig. 4C), and its oligomeric
structure, which confers one to six negative charges to tubulin
(20, 21, 22, 23), can explain the progressive variation of RK binding observed
as a function of tubulin acidification. It appears that addition of the
first three glutamyl units increases the affinity of tubulin for
kinesin, whereas further lengthening of the post-translational chain
decreases it.
Fig. 4.
RK375 binding to the different - and
-isotubulins: influence of polyglutamylation. Tubulin was
separated by high resolution two-dimensional PAGE and tranferred onto
nitrocellulose. A, control. The different - and
-isotubulins were immunodetected with DM1A then with DM1B,
respectively. B, overlay. A parallel blot was overlaid with
RK375 (2 µg·ml 1), and tubulin-bound kinesin was
immunodetected with anti-HIPYR. C, the different
polyglutamylated - and -isotubulins were immunolocalized with
GT335. 0 and 1 6 indicate the number of
glutamyl units carried by the post-translationally modified tubulins.
0 corresponds to the unmodified primary translation tubulin
products. The brackets are positioned in the same
co-ordinates in the three panels.
[View Larger Version of this Image (51K GIF file)]
Competition with Monoclonal Anti-tubulin Antibodies
To
explain the influence of polyglutamylation on kinesin binding, an
attempt was made to block the post-translational chains with a
monoclonal antibody raised in our laboratory, GT335, which specifically
recognizes the polyglutamylated motif on - and -tubulin (27). As
a control, four other anti-tubulin monoclonal antibodies were used in
parallel to block their respective epitopes, all located also in the
carboxyl-terminal domain (Fig. 5F): the
anti-tyrosinated -tubulin YL1/2, the anti- -tubulin YOL1/34, and
two general anti- - and anti- -tubulin, DM1A and DM1B, respectively
(29, 30). Purified brain tubulin was separated by one-dimensional PAGE,
transferred onto nitrocellulose, and progressively saturated by
increasing concentrations of each monoclonal antibody. After extensive
washing to eliminate unbound antibodies, membrane strips were overlaid
with RK375, and tubulin-bound kinesin was detected with the polyclonal
anti-HIPYR antibody and a peroxidase-labeled anti-rabbit IgG, to avoid
any cross-reaction with the previously bound mouse IgG (Fig. 5,
A-E).
Fig. 5.
RK375 binding to tubulin protected with
monoclonal antibodies. Tubulin (2 µg) was separated by
one-dimensional PAGE, transferred onto nitrocellulose, and incubated
with increasing concentrations of the following monoclonal antibodies:
GT335 (A), YL1/2 (B), DM1A (C), DM1B
(D), or YOL1/34 (E). F indicates their
epitope locations in the carboxyl-terminal domains of - and
-tubulin subunits. After extensive washing to eliminate unbound
antibodies, blot strips were overlaid with RK375 (2 µg·ml 1). RK375 binding to - or -tubulin
subunits was quantified after immunodetection with the polyclonal
anti-HIPYR antibody and expressed as a percentage of control binding
(without prior blocking antibody) as a function of antibody
dilution.
[View Larger Version of this Image (29K GIF file)]
Increasing fixation of GT335 on the polyglutamyl chains progressively
and rapidly inhibited kinesin binding on both tubulin subunits (Fig.
5A). A similar binding inhibition by GT335 was previously
observed for Tau (24). Fixation of YL1/2 on its carboxyl-terminal
tyrosylated epitope of -tubulin did not significantly affect the
binding of RK375 (Fig. 5B). Fixation of DM1A and DM1B
interfered with kinesin binding on the - and the -tubulin
subunit, respectively (Fig. 5, C and D), DM1A
being much more efficient than DM1B in binding inhibition. In the
presence of YOL1/34, a significant inhibition of RK binding to
-tubulin was also observed (Fig. 5E). In these
experiments, binding of RK to -tubulin in the presence of YL1/2,
YOL1/34, or DM1A and to -tubulin in the presence of DM1B served as
internal controls.
Binding of Kinesin to Subtilisin-cleaved Tubulin
With
antibody blocking experiments, it is difficult to know at first whether
the observed inhibition is a direct effect, that is, a coincidence of
the ligand binding site and the antibody epitope, or is due indirectly
to a steric hindrance of the large IgG molecule, which can block the
accessibility of adjacent binding sites. For the inhibition observed
with GT335, at least, the corresponding epitopes can be easily removed
by digesting tubulin with subtilisin (24, 31, 32). In this case, after
blot overlay with RK375 of partially or totally digested tubulin (Fig.
6), it appeared that kinesin still bound to cleaved
( S and S) tubulin. Densitometric integration of the
autoradiograms indicated that (i) RK375 interacted with the same
efficiency with intact - and -tubulin, (ii) S and S bound
less kinesin than uncleaved - and -subunit, respectively, and
(iii) S bound approximately two times less kinesin than S.
Although kinesin binding efficiency was decreased with
subtilisin-cleaved tubulin, it is clear that RK375 did still bind to
the carboxyl terminus-deleted tubulin, indicating that the kinesin
binding sites are not located in the extreme carboxyl-terminal domain
of tubulin but rather upstream of or even close to the subtilisin
cleavage sites (Asp438 for -tubulin and
Gln433 for -tubulin (32)). Altogether, the results from
Figs. 4, 5, and 6 suggest that polyglutamylation of tubulin controls
kinesin binding through an indirect, conformational change of the
carboxyl-terminal domain of tubulin, as previously reported for Tau or
MAP2 binding (24).
Fig. 6.
RK375 binding to subtilisin-cleaved
tubulin. Tubulin was submitted to a total (lane 2) or a
partial (lane 3) digestion with subtilisin and separated by
one-dimensional PAGE with undigested tubulin (lane 1) as
reference. Left panel, control: double immunodetection with
DM1A then DM1B of cleaved ( S and S) and uncleaved ( and )
tubulin subunits. Right panel, overlay: immunodetection with
anti-HIPYR of RK375 bound to the different tubulin products.
[View Larger Version of this Image (32K GIF file)]
Moreover, it is relevant that compared with intact tubulin, kinesin
binding is less affected than Tau binding by subtilisin cleavage (data
not shown). Combined with the observations that DM1A prevented kinesin
but not Tau binding and that both are under the same control by
polyglutamylation, it can be concluded that the binding sites for
kinesin and Tau are distinct, although sufficiently close together
within the carboxyl-terminal domain. The Tau binding site would be
downstream from that of kinesin, ending, at least, in the vicinity of
the subtilisin cleavage site.
Binding Sites for Structural and Motor MAPs
To get
information about the respective binding sites for structural and motor
MAPs on the tubulin molecule and to know whether the different MAP
classes can compete with each other, the following experiments were
carried out. Constant amounts of tubulin were separated by
one-dimensional PAGE and transferred onto three nitrocellulose
membranes that were incubated with increasing concentrations of
heat-stable MAP from brain (Fig. 7). As control,
tubulin-bound Tau was detected and quantified on blot 1 using the
monoclonal antibody Tau-1; as shown in Fig. 7 (dotted line),
the Tau binding sites were effectively saturated from 4 µg·ml 1 onwards. On blot 2, a second overlay was
performed with a constant amount of RK375; tubulin-bound kinesin was
detected and quantified with anti-HIPYR. As illustrated in Fig. 7
(dashed line), the binding level of RK375 was constant and
independent of the amount of Tau previously bound to tubulin,
indicating that kinesin head interaction was not impeded by bound Tau.
To rule out the possibility that bound Tau could have been displaced by
RK375, blot 3 was processed as blot 2 except that tubulin-Tau
interactions were stabilized with formaldehyde between the first
overlay with Tau and the second with RK375 (Fig. 7, solid
line). The comparison of the binding curves shows that
stabilization of the tubulin-Tau complexes did not modify the constant
interaction of RK375 with Tau-saturated tubulin. Altogether, these
results strongly suggest that the binding sites for Tau and kinesin on
the tubulin subunit molecules are independent.
Fig. 7.
Competition binding experiments with Tau and
kinesin. Tubulin (2 µg) was separated by one-dimensional PAGE,
transferred onto nitrocellulose, and overlaid with increasing
concentrations of heat stable MAP (0-10 µg·ml 1).
This experiment was done in triplicate. Dotted line,
control: first series of blot strips immunodetected with Tau-1.
Dashed line, second series immunodetected with anti-HIPYR
after a second overlay with a constant concentration (2 µg·ml 1) of RK375. Solid line, third series
processed in the same manner as the second one except that Tau-tubulin
interactions were stabilized with formaldehyde before the second
overlay with RK375. The results are expressed in arbitrary units.
[View Larger Version of this Image (23K GIF file)]
DISCUSSION
Interactions between Tubulin Subunits and Kinesin
Kinesin is
a plus-end-directed microtubule motor that binds to MTs with a
longitudinal periodicity of 8 nm, corresponding to that of a tubulin
dimer (33, 34), and moves along a single protofilament track (35, 36)
with 8-nm steps (37). In agreement with the binding stoichiometry and
the step increments, three-dimensional map structures of MT-bound
kinesin reconstructed after electron microscopy and image analysis have
shown recently that kinesin steps over two adjacent tubulin monomers
along a protofilament axis, the motor domain being closer to one
monomer than to the other (38, 39, 40, 41). Upon interaction and nucleotide
binding, large scale conformational changes were also revealed in
tubulin (39) and in kinesin (38). To characterize the tubulin
subunit(s) targeted by kinesin, cross-linking experiments have
identified either the -tubulin (34, 42) or both the - and
-tubulin (43). These different results could mean that the kinesin
motor domain sits well on both tubulin subunits; it is closer to
-tubulin, however, in agreement with the structural data.
In this paper, we used a quite different approach by blot overlay to
study the interaction between tubulin and kinesin. We showed that the
kinesin head domain binds to both - and -tubulin monomers with
the same apparent affinity. Under the conditions used here, tubulin
monomers are quite separated on blots; they play their own part and
cannot receive conformational information from the other subunit(s), as
is the case in the heterodimeric structure and especially in a MT. It
remains, however, that our results show that each - or -tubulin
monomer has the intrinsic property to interact with kinesin. Moreover,
all of the effectors tested in the binding assays modulate in the same
way and at the same extent the binding to both tubulin subunits,
indicating that both monomers share the same binding features for
kinesin. Inhibition of kinesin binding on - and -tubulin by
competitive free tubulin added in the overlay solution as well as the
selective binding of RK to tubulin in a whole protein extract (see Fig.
1B) indicate further that RK binding was specific.
Interaction of Tubulin with Plus- or Minus-end-directed
Kinesin
Comparison of binding properties of the conventional RK
motor domain with those of the reverse, minus-end-directed
Drosophila kinesin-related protein ncd showed no significant
quantitative or qualitative difference. In particular, both tubulin
subunits were bound at similar levels by the two motors. Moreover, when
analyzed by blot overlay after separation of tubulin by two-dimensional
PAGE, the ncd motor bound differentially to the diverse isotubulins as
a function of their degree of polyglutamylation (data not shown)
following a pattern quite similar to that observed with RK375. Thus,
the vectorial specificity of the motors within the kinesin superfamily,
moving toward the plus- or the minus-end of a MT, does not seem to be
related to their preferential binding to a given - or -tubulin
subunit (which could have been sufficient to confer to the motor
protein a specific position on the MT and hence a given polarity of
translocation). Furthermore, because it has been reported that changing
the motor domain from its normal amino-terminal position to an ectopic
carboxyl-terminal location does not reverse the direction of its
movement along the MT (44) and that both plus- and minus-end-directed
motors compete for the same binding site on tubulin (45), it appears
that the directional specificity of a kinesin motor has to be
researched subtly in the kinesin amino acid sequences and/or in the
fine tune interaction with tubulin.
Binding of the Truncated Form of Kinesin Head, RK329
The net
decrease in the ability of the truncated motor domain RK329 to bind
tubulin points to the amino acids 330-379 peptide segment. The
presence of this segment could help the upstream region, described as
the boundary of the MT-binding domain (46), to adopt the right
conformation. More precisely, this region could be involved in the
dimerization of head domains. As previously reported (28), the high
-helical propensity observed in the stalk, which extends up to
position 340, is compatible with a coiled-coil structure just after the
head domain. Because a 340- or 357-amino acid kinesin construct is
monomeric and a 392-amino acid one is dimeric (28), the 379-amino acid
rat kinesin construct used here might also be dimerized in solution.
Practically, when RK329 and RK375 were analyzed by HPLC gel filtration,
RK329 was eluted later than RK375, with elution times compatible with a
monomeric state for RK329 and a dimeric state for RK375 (see Fig.
3C). In theory, the difference in the binding of RK329
versus RK375 in the overlay or enzyme-linked immunosorbent
assay-type experiments, as revealed by antibody detection, should thus
have been in a ratio of 1:2. Instead, the 5-10-fold decrease we
observed suggests that dimerization could drive a conformational change
in the tubulin binding site of the kinesin head domain, increasing its
affinity for tubulin.
Tubulin Binding Sites for Structural and Motor MAPs
Several
experiments reported here indicate that Tau and kinesin have distinct
binding sites on the tubulin molecule, confirming previous reports
(47, 48, 49, 50, 51). In competition experiments, Tau and kinesin bound
independently to tubulin (see Fig. 7). In addition, antibody blocking
experiments using DM1A and DM1B led to quite different results;
although neither antibody affected the binding of Tau (24), they
significantly interfered with that of kinesin; DM1A has a more
pronounced effect than DM1B (see Fig. 5).
Although independent, these binding sites must be sufficiently close to
each other, however, within the carboxyl-terminal domain of tubulin.
Both sites are under the control of tubulin polyglutamylation, which is
thought to alter the conformation of the whole carboxyl-terminal domain
as a function of the post-translational chain length (see Fig. 4 and
Ref. 24). Moreover, it has been reported that the projection domain of
MAP2, and eventually that of Tau, could interfere with kinesin binding
(47, 50, 52), suggesting that if the binding sites are distinct, they
are not far from each other.
The extreme carboxyl-terminal sequences of - and -tubulins
carrying the polyglutamyl chains can be cleaved with subtilisin. In
this case, there is a 2-fold decrease in kinesin binding and a more
pronounced effect in Tau binding, suggesting that the Tau binding site
is closer to the subtilisin cleavage site and hence downstream relative
to the kinesin binding site. Moreover, it has been reported that
taxol-stabilized MTs cut with subtilisin (instead of soluble tubulin
dimers, as in this paper) retained the property to bind kinesin but
lost completely (48, 51) or partially (52, 53) the property to bind
Tau, due to the cleavage of the -subunit in the latter case.
It remains difficult, however, to assign more precise locations for the
kinesin and Tau binding sites on linear representations of tubulin
molecules (Fig. 8A). All of the results from
the literature point to region II of the carboxyl-terminal domain of
the tubulin subunits described by Goldsmith et al. (26),
corresponding to sequences highly conserved within each tubulin subunit
(Fig. 8A). Secondary structure predictions (54, 55) have
suggested that most of the sequences in region II form an anionic
-helix (from amino acids 413-418 to amino acids 434-436 in
-tubulin and from amino acid 407 to amino acid 426 in -tubulin),
which likely corresponds to the ~25-Å-long density observed by
Nogales et al. (55). It is interesting to note that in
agreement with the putative structure we published recently (24), the
DM1A and YOL1/34 epitopes are superimposed on the external face of this
helix (Fig. 8B), leaving enough room for protein binding
sites on the internal, anionic face. We suggest that the accessibility
of these internal binding sites is controlled by the polyglutamyl
chains located downstream (anchored at residues Glu445 in
-tubulin and Glu435 in class II -tubulin; see Refs.
20, 32, and 56). In this view, the accessibility of this anionic face
would be blocked in the nonglutamylated tubulin by the interaction with
the cationic face of an upstream -helix (amino acids 385-403 in
-tubulin and amino acids 371-391 in -tubulin, Fig.
8A) through ionic bonds. This binding inhibition would then
be released by the negatively charged polyglutamyl chains, which would
compete with the ionic bonds and move the two helices apart from each
other, giving thus the accessibility to the MAP binding sites (see also
Ref. 24).
Fig. 8.
Binding sites for Tau and kinesin in the
carboxyl-terminal domain of tubulin. A, carboxyl-terminal
domains of - and -tubulin. The last 60 amino acids of both
subunits are represented. I, II, and
III correspond to the three regions described by Goldsmith
et al. (26) and are delimited by boxed amino acid numbers.
I, conserved between both subunits; II, conserved
within each subunit only; III, isotype-specific. Epitope
locations of DM1A, DM1B, and YOL1/34 are noted, as well as the
subtilisin cleavage sites. E represents the
polyglutamylation sites. The black boxes represent the 430-441 and the 422-434 peptides previously reported as the
putative Tau binding sites (58). The shaded box represents
the 400-436 peptide reported to encompass the general motor
binding site (26). Striped boxes represent the locations of
predicted -helices (see text). B, schematic
representation of the carboxyl-terminal domain of -tubulin from
residues 410 to 451. The second 413-434 -helix is shown as a
cylinder with the monoclonals YOL1/34 and DM1A bound, one above the
other, on its outer surface; the deduced Tau and kinesin binding sites
are positioned on the inner face of the helix (see text). Downstream
are indicated the subtilisin cleavage site and the bound monoclonals
GT335 and YL1/2.
[View Larger Version of this Image (26K GIF file)]
It is relevant that GT335, which readily inhibits both Tau and kinesin
binding, has also been shown recently to strongly inhibit dynein-based
flagellar motility (57), suggesting that the polyglutamyl chains could
play a crucial role in controlling the whole carboxyl-terminal domain
of tubulin. Experiments are in progress to test and complete the data
with other structural and motor MAPs.
FOOTNOTES
*
This work was supported by the Centre National de la
Recherche Scientifique. The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
``advertisement'' in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
33-1-44-27-13-03; Fax: 33-1-44-27-13-09.
1
The abbreviations used are: MT, microtubule;
PAGE, polyacrylamide gel electrophoresis; MAP, microtubule-associated
protein; MES, 2-(N-morpholino)ethanesulfonic acid; RK, rat kinesin;
ncd, nonclaret disjunctional; PIPES, 1,4-piperazinediethanesulfonic
acid; MEM, MES-EGTA-MgCl2 buffer; OV, overlay buffer; HPLC,
high pressure liquid chromatography.
Acknowledgments
We are grateful to E.-M. Mandelkow and F. Kozielski for generously providing the recombinant motor domains of rat
kinesin (from the original clone from S. T. Brady) and
Drosophila ncd, T. J. Mitchison and J. Kilmartin for the
kind gift of specific antibodies against kinesin (anti-HIPYR) and
tubulin (YOL1/34), R. Guénard for providing Taxol, J. Pothier for
tubulin structure prediction analysis, and B. Eddé for HPLC
analyses.
REFERENCES
-
Tucker, R. P.
(1990)
Brain Res. Rev.
15,
101-120
[CrossRef][Medline]
[Order article via Infotrieve]
-
Vale, R. D.
(1992)
Trends Biochem. Sci.
17,
300-304
[CrossRef][Medline]
[Order article via Infotrieve]
-
Walker, R. A.,
Sheetz, M. P.
(1993)
Annu. Rev. Biochem.
62,
429-451
[CrossRef][Medline]
[Order article via Infotrieve]
-
Mandelkow, E.,
Mandelkow, E.-M.
(1995)
Curr. Opin. Cell Biol.
7,
72-81
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lindwall, G.,
Cole, R. D.
(1984)
J. Biol. Chem.
259,
5301-5305
[Abstract/Free Full Text]
-
Brugg, B.,
Matus, A.
(1991)
J. Cell Biol.
114,
735-743
[Abstract/Free Full Text]
-
Biernat, J.,
Gustke, N.,
Drewes, G.,
Mandelkow, E.-M.,
Mandelkow, E.
(1993)
Neuron
11,
153-163
[CrossRef][Medline]
[Order article via Infotrieve]
-
Liao, H.,
Li, G.,
Yen, T. J.
(1994)
Science
265,
394-398
[Abstract/Free Full Text]
-
Allan, V.
(1995)
J. Cell Biol.
127,
1671-1681
[Abstract/Free Full Text]
-
Blangy, A.,
Lane, H. A.,
Hérin, P.,
Harper, M.,
Kress, M.,
Nigg, E. A.
(1995)
Cell
83,
1159-1169
[CrossRef][Medline]
[Order article via Infotrieve]
-
Okada, Y.,
Sato-Yoshitake, R.,
Hirokawa, N.
(1995)
J. Neurosci.
15,
3053-3064
[Abstract]
-
Miller, R. H.,
Lasek, R. J.,
Katz, M. J.
(1987)
Science
235,
220-222
[Abstract/Free Full Text]
-
Nislow, C.,
Lombillo, V. A.,
Kuriyama, R.,
McIntosh, J. R.
(1992)
Nature
359,
543-547
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sawin, K. E.,
Mitchison, T. J.,
Wordeman, L. G.
(1992)
J. Cell Sci.
101,
303-313
[Abstract/Free Full Text]
-
Yen, T. J.,
Li, G.,
Schaar, B. T.,
Szilak, I.,
Cleveland, D. W.
(1992)
Nature
359,
536-539
[CrossRef][Medline]
[Order article via Infotrieve]
-
Bernstein, M.,
Beech, P. L.,
Katz, S. G.,
Rosenbaum, J. L.
(1994)
J. Cell Biol.
125,
1313-1326
[Abstract/Free Full Text]
-
Sullivan, K. F.
(1988)
Annu. Rev. Cell Biol.
4,
687-716
[CrossRef]
-
Murphy, D. B.
(1991)
Curr. Opin. Cell Biol.
3,
43-51
[CrossRef][Medline]
[Order article via Infotrieve]
-
Luduena, R. F.
(1993)
Mol. Biol. Cell
4,
445-457
[Medline]
[Order article via Infotrieve]
-
Eddé, B.,
Rossier, J.,
Le Caer, J.-P.,
Desbruyères, E.,
Gros, F.,
Denoulet, P.
(1990)
Science
247,
83-85
[Abstract/Free Full Text]
-
Audebert, S.,
Desbruyères, E.,
Gruszczynski, C.,
Koulakoff, A.,
Gros, F.,
Denoulet, P.,
Eddé, B.
(1993)
Mol. Biol. Cell
4,
615-626
[Abstract]
-
Audebert, S.,
Koulakoff, A.,
Berwald-Netter, Y.,
Gros, F.,
Denoulet, P.,
Eddé, B.
(1994)
J. Cell Sci.
107,
2313-2322
[Abstract]
-
Wolff, A.,
Houdayer, M.,
Chillet, D.,
de Néchaud, B.,
Denoulet, P.
(1994)
Biol. Cell.
81,
11-16
[CrossRef][Medline]
[Order article via Infotrieve]
-
Boucher, D.,
Larcher, J.-C.,
Gros,
Denoulet, P.
(1994)
Biochemistry
33,
12471-12477
[CrossRef][Medline]
[Order article via Infotrieve]
-
Paschal, B. M.,
Obar, R. A.,
Vallee, R. B.
(1989)
Nature
342,
569-572
[CrossRef][Medline]
[Order article via Infotrieve]
-
Goldsmith, M.,
Connolly, J. A.,
Kumar, N.,
Wu, J.,
Yarbrough, L. R.,
van der Kooy
(1991)
Cell Motil. Cytoskeleton
20,
249-262
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wolff, A.,
de Néchaud, B.,
Chillet, D.,
Mazarguil, H.,
Desbruyères, E.,
Audebert, S.,
Eddé, B.,
Gros, F.,
Denoulet, P.
(1992)
Eur. J. Cell Biol.
59,
425-432
[Medline]
[Order article via Infotrieve]
-
Huang, T.-G.,
Suhan, J.,
Hackney, D. D.
(1994)
J. Biol. Chem.
269,
16502-16507
[Abstract/Free Full Text]
-
Breitling, F.,
Little, M.
(1986)
J. Mol. Biol.
189,
367-370
[CrossRef][Medline]
[Order article via Infotrieve]
-
Andreu, J. M.,
de Pereda, J. M.
(1993)
Cell Motil. Cytoskeleton
26,
1-6
[CrossRef][Medline]
[Order article via Infotrieve]
-
Serrano, L. J.,
Avila, J.,
Maccioni, R. B.
(1984)
Biochemistry
23,
4675-4681
[CrossRef][Medline]
[Order article via Infotrieve]
-
Redecker, V.,
Melki, R.,
Promé, D.,
Le Caer, J.-P.,
Rossier, J.
(1992)
FEBS Lett.
313,
185-192
[CrossRef][Medline]
[Order article via Infotrieve]
-
Harrison, B. C.,
Marchese-Ragona, S. P.,
Gilbert, S. P.,
Cheng, N.,
Steven, A. C.,
Johnson, K. A.
(1993)
Nature
362,
73-75
[CrossRef][Medline]
[Order article via Infotrieve]
-
Song, Y.-H.,
Mandelkow, E.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
1671-1675
[Abstract/Free Full Text]
-
Gelles, J.,
Schnapp, B. J.,
Sheetz, M. P.
(1988)
Nature
331,
450-453
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ray, S.,
Meyhöfer, E.,
Milligan, R. A.,
Howard, J.
(1993)
J. Cell Biol.
121,
1083-1093
[Abstract/Free Full Text]
-
Svoboda, K.,
Schmidt, C. F.,
Schnapp, B. J.,
Block, S. M.
(1993)
Nature
365,
721-727
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hirose, K.,
Lockhart, A.,
Cross, R. A.,
Amos, L. A.
(1995)
Nature
376,
277-279
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hoenger, A.,
Sablin, E. P.,
Vale, R. D.,
Fletterick, R. J.,
Milligan, R. A.
(1995)
Nature
376,
271-274
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kikkawa, M.,
Ishikawa, T.,
Wakabayashi, T.,
Hirokawa, N.
(1995)
Nature
376,
274-277
[CrossRef][Medline]
[Order article via Infotrieve]
-
Song, Y.-H.,
Mandelkow, E.
(1995)
J. Cell Biol.
128,
81-94
[Abstract/Free Full Text]
-
Kikkawa, M.,
Ishikawa, T.,
Nakata, T.,
Wakabayashi, T.,
Hirokawa, N.
(1994)
J. Cell Biol.
127,
1965-1971
[Abstract/Free Full Text]
-
Walker, R. A.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
5960-5964
[Abstract/Free Full Text]
-
Stewart, R. J.,
Thaler, J. P.,
Goldstein, L. S. B.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
5209-5213
[Abstract/Free Full Text]
-
Lockhart, A.,
Crevel, I. M.-T.,
Cross, R. A.
(1995)
J. Mol. Biol.
249,
763-771
[CrossRef][Medline]
[Order article via Infotrieve]
-
Yang, J. T.,
Laymon, R. A.,
Goldstein, L. S. B.
(1989)
Cell
56,
879-889
[CrossRef][Medline]
[Order article via Infotrieve]
-
Massow, A.,
Mandelkow, E.-M.,
Mandelkow, E.
(1989)
Cell Motil. Cytoskeleton
14,
562-571
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rodionov, V. I.,
Gyoeva, F. K.,
Kashina, A. S.,
Kuznetsov, S. A.,
Gelfand, V. I.
(1990)
J. Biol. Chem.
265,
5702-5707
[Abstract/Free Full Text]
-
Heins, S.,
Song, Y. H.,
Wille, H.,
Mandelkow, E.,
Mandelkow, E.-M.
(1991)
J. Cell Sci. (Suppl.)
14,
121-124
[Medline]
[Order article via Infotrieve]
-
Lopez, L. A.,
Sheetz, M. P.
(1993)
Cell Motil. Cytoskeleton
24,
1-16
[CrossRef][Medline]
[Order article via Infotrieve]
-
Marya, P. K.,
Syed, Z.,
Fraylich, P. E.,
Eagles, P. A. M.
(1994)
J. Cell Sci.
107,
339-344
[Abstract]
-
Hagiwara, H.,
Yorifuji, H.,
Sato-Yoshitake, R.,
Hirokawa, N.
(1994)
J. Biol. Chem.
269,
3581-3589
[Abstract/Free Full Text]
-
Melki, R.,
Kerjan, P.,
Waller, J.-P.,
Carlier, M. F.,
Pantaloni, D.
(1991)
Biochemistry
30,
11536-11545
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ponstingl, H.,
Little, M.,
Krauhs, E.,
Kempf, T.
(1979)
Nature
282,
423-424
[CrossRef][Medline]
[Order article via Infotrieve]
-
Nogales, E.,
Wolf, S. G.,
Khan, I. A.,
Luduena, R. F.,
Downing, K.
H.
(1995)
Nature
375,
424-427
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rüdiger, M.,
Plessman, U.,
Klöppel, D.,
Wehland, J.,
Weber, K.
(1992)
FEBS Lett.
308,
101-105
[CrossRef][Medline]
[Order article via Infotrieve]
-
Gagnon, C., White, D., Cosson, J., Huitorel, P., Eddé, B.,
Desbruyères, E., Paturle-Lafanechère, L., Multigner, L.,
Job, D., and Cibert, C. (1996) J. Cell Sci., in press
-
Maccioni, R. B.,
Rivas, C. I.,
Vera, J. C.
(1988)
EMBO J.
7,
1957-1963
[Medline]
[Order article via Infotrieve]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Maas, D. Belgardt, H. K. Lee, F. F. Heisler, C. Lappe-Siefke, M. M. Magiera, J. van Dijk, T. J. Hausrat, C. Janke, and M. Kneussel
Synaptic activation modifies microtubules underlying transport of postsynaptic cargo
PNAS,
May 26, 2009;
106(21):
8731 - 8736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Wloga, K. Rogowski, N. Sharma, J. Van Dijk, C. Janke, B. Edde, M.-H. Bre, N. Levilliers, V. Redeker, J. Duan, et al.
Glutamylation on {alpha}-Tubulin Is Not Essential but Affects the Assembly and Functions of a Subset of Microtubules in Tetrahymena thermophila
Eukaryot. Cell,
August 1, 2008;
7(8):
1362 - 1372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. van Dijk, J. Miro, J.-M. Strub, B. Lacroix, A. van Dorsselaer, B. Edde, and C. Janke
Polyglutamylation Is a Post-translational Modification with a Broad Range of Substrates
J. Biol. Chem.,
February 15, 2008;
283(7):
3915 - 3922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. T. Spiliotis, S. J. Hunt, Q. Hu, M. Kinoshita, and W. J. Nelson
Epithelial polarity requires septin coupling of vesicle transport to polyglutamylated microtubules
J. Cell Biol.,
January 28, 2008;
180(2):
295 - 303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ikegami, R. L. Heier, M. Taruishi, H. Takagi, M. Mukai, S. Shimma, S. Taira, K. Hatanaka, N. Morone, I. Yao, et al.
Loss of {alpha}-tubulin polyglutamylation in ROSA22 mice is associated with abnormal targeting of KIF1A and modulated synaptic function
PNAS,
February 27, 2007;
104(9):
3213 - 3218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ikegami, M. Mukai, J.-i. Tsuchida, R. L. Heier, G. R. MacGregor, and M. Setou
TTLL7 Is a Mammalian beta-Tubulin Polyglutamylase Required for Growth of MAP2-positive Neurites
J. Biol. Chem.,
October 13, 2006;
281(41):
30707 - 30716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Goping, T. Sawchuk, D. A. Underhill, and R. C. Bleackley
Identification of {alpha}-tubulin as a granzyme B substrate during CTL-mediated apoptosis.
J. Cell Sci.,
March 1, 2006;
119(Pt 5):
858 - 865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Redeker, N. Levilliers, E. Vinolo, J. Rossier, D. Jaillard, D. Burnette, J. Gaertig, and M.-H. Bre
Mutations of Tubulin Glycylation Sites Reveal Cross-talk between the C Termini of {alpha}- and {beta}-Tubulin and Affect the Ciliary Matrix in Tetrahymena
J. Biol. Chem.,
January 7, 2005;
280(1):
596 - 606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Jouvenet, P. Monaghan, M. Way, and T. Wileman
Transport of African Swine Fever Virus from Assembly Sites to the Plasma Membrane Is Dependent on Microtubules and Conventional Kinesin
J. Virol.,
August 1, 2004;
78(15):
7990 - 8001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yoshiyama, B. Zhang, J. Bruce, J. Q. Trojanowski, and V. M.-Y. Lee
Reduction of Detyrosinated Microtubules and Golgi Fragmentation Are Linked to Tau-Induced Degeneration in Astrocytes
J. Neurosci.,
November 19, 2003;
23(33):
10662 - 10671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Regnard, D. Fesquet, C. Janke, D. Boucher, E. Desbruyeres, A. Koulakoff, C. Insina, P. Travo, and B. Edde
Characterisation of PGs1, a subunit of a protein complex co-purifying with tubulin polyglutamylase
J. Cell Sci.,
October 15, 2003;
116(20):
4181 - 4190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Banerjee
Coordination of Posttranslational Modifications of Bovine Brain alpha -Tubulin. POLYGLYCYLATION OF Delta 2 TUBULIN
J. Biol. Chem.,
November 22, 2002;
277(48):
46140 - 46144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. McKean, S. Vaughan, and K. Gull
The extended tubulin superfamily
J. Cell Sci.,
January 8, 2001;
114(15):
2723 - 2733.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Regnard, E Desbruyeres, P Denoulet, and B Edde
Tubulin polyglutamylase: isozymic variants and regulation during the cell cycle in HeLa cells
J. Cell Sci.,
January 12, 1999;
112(23):
4281 - 4289.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K Million, J Larcher, J Laoukili, D Bourguignon, F Marano, and F Tournier
Polyglutamylation and polyglycylation of alpha- and beta-tubulins during in vitro ciliated cell differentiation of human respiratory epithelial cells
J. Cell Sci.,
January 12, 1999;
112(23):
4357 - 4366.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S Westermann, A Schneider, E. Horn, and K Weber
Isolation of tubulin polyglutamylase from Crithidia; binding to microtubules and tubulin, and glutamylation of mammalian brain alpha- and beta-tubulins
J. Cell Sci.,
January 7, 1999;
112(13):
2185 - 2193.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Bobinnec, A. Khodjakov, L.M. Mir, C.L. Rieder, B. Edde, and M. Bornens
Centriole Disassembly In Vivo and Its Effect on Centrosome Structure and Function in Vertebrate Cells
J. Cell Biol.,
December 14, 1998;
143(6):
1575 - 1589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Liao and G. G. Gundersen
Kinesin Is a Candidate for Cross-bridging Microtubules and Intermediate Filaments. SELECTIVE BINDING OF KINESIN TO DETYROSINATED TUBULIN AND VIMENTIN
J. Biol. Chem.,
April 17, 1998;
273(16):
9797 - 9803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Mathe, I Boros, K Josvay, K Li, J Puro, T. Kaufman, and J Szabad
The Tomaj mutant alleles of alpha Tubulin67C reveal a requirement for the encoded maternal specific tubulin isoform in the sperm aster, the cleavage spindle apparatus and neurogenesis during embryonic development in Drosophila
J. Cell Sci.,
January 4, 1998;
111(7):
887 - 896.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Regnard, E. Desbruyeres, J.-C. Huet, C. Beauvallet, J.-C. Pernollet, and B. Edde
Polyglutamylation of Nucleosome Assembly Proteins
J. Biol. Chem.,
May 19, 2000;
275(21):
15969 - 15976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Spittle, S. Charrasse, C. Larroque, and L. Cassimeris
The Interaction of TOGp with Microtubules and Tubulin
J. Biol. Chem.,
June 30, 2000;
275(27):
20748 - 20753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bonnet, D. Boucher, S. Lazereg, B. Pedrotti, K. Islam, P. Denoulet, and J. C. Larcher
Differential Binding Regulation of Microtubule-associated Proteins MAP1A, MAP1B, and MAP2 by Tubulin Polyglutamylation
J. Biol. Chem.,
April 13, 2001;
276(16):
12839 - 12848.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|